期刊文献+

塞来昔布对脂多糖诱导的多巴胺能神经元变性的保护作用 被引量:1

Neuroprotective effects of celecoxib against degeneration of dopaminergic neurons induced by lipopolysaccharide
下载PDF
导出
摘要 目的探讨选择性环氧化酶-2(COX-2)抑制剂塞来昔布对细菌脂多糖(LPS)诱导的多巴胺能神经元变性的保护作用及其机制。方法30只SD大鼠随机分成3组:PBS对照组、生理盐水+LPS(生理盐水治疗组)和塞来昔布+LPS(塞米昔布治疗组),每组10只。黑质内立体定向注射15μg LPS或PBS 14天后,采用免疫组织化学法观察大鼠黑质酪氨酸羟化酶(TH)阳性细胞的减少以及小胶质细胞的形态学变化,免疫印迹法检测黑质COX-2蛋白表达以及放射免疫法测定前列腺素E2(PGE2)和TNF-α水平。结果与PBS对照组比较,生理盐水治疗组TH阳性细胞减少到对侧的16%(P<0.01),黑质COX-2蛋白表达以及PGE2、TNF-α含量明显增加,大部分小胶质细胞呈激活形态;塞来昔布治疗组TH阳性细胞数较生理盐水治疗组明显增多,为对侧的43%(P<0.05),黑质COX-2蛋白表达以及PGE2、TNF-α含量明显减少,激活的小胶质细胞明显减少。结论COX-2涉及炎症介导的多巴胺能神经元变性机制,塞来昔布能抑制小胶质细胞激活,阻止多巴胺能神经元的变性和丢失。 Objectives To explore the effect and possible mechanism of celecoxib on degeneration of dopaminergic neurons induced by intranigral injection of lipopolysaccharide(LPS). Methods Thirty female Sprague-Dawley rats were randomly divided into three groups:PBS group, physiologic saline +LPS group and celecoxib+LPS group. On d 14 after injection of LPS 15 μg or PBS, the number of tyrosine hydroxylase (TH)-positive neurons and the morphological changes of OX-42 positive microglias in the substantia nigra(SN) were observed by immunohistochemistry. COX-2 protein expression was examined by immunoblotting,prostaglandin E2 (PGE2) and tumor necrosis factor α (TNF-α) contents were measured with radioimmunoassay. Results Compared with PBS control group,TH-positive neurons in the SN on the LPS-injected side reduced to 16% of the opposite side in saline treated group( P (0.05) ,COX-2 protein expression and PGE2 and TNF-α contents in SN were upregulated. Compared with saline treated group,43% TH-positive neurons survived in celecoxib treated group, ( P 〈0.05) and celecoxib significantly lowered the levels of PGE2 ,TNF-α and the microglial activation. Conclusions COX-2 may be involved in LPS- induced dopaminergic neurous degeneration. Celecoxib inhibits microglial activation and the neurotoxic secretions,prevents the dopaminergic neuron degeneration and loss.
出处 《中华老年心脑血管病杂志》 CAS 北大核心 2007年第7期485-488,共4页 Chinese Journal of Geriatric Heart,Brain and Vessel Diseases
关键词 帕金森病 多巴胺 脂多糖类 环加氧酶抑制药 大鼠 Parkinson disease dopamine lipopolysaccharides cyclooxygenase inhibitors rats
  • 相关文献

参考文献1

二级参考文献40

  • 1Chou SM, Wang HS, Komai K. Colocalization of NOS and SOD1 in neurofilament accumulation within motor neurons of amyotrophic lateral sclerosis: an immunohistochemical study. J Chem Neuroanat 1996; 10: 249.
  • 2Sasaki S, Shibata N, Komori T, Iwata M. iNOS and nitro tyrosine immunoreactivity in amyotrophic lateral sclerosis. Neurosci Lett2000; 291: 44.
  • 3Almer G, Vukosavic S, Romero N, Przedborski S. Inducible nitric oxide synthase upregulation in a transgenic mouse model of familial amyotrophic lateral sclerosis. J Neurochem 1999; 72:2415-25.
  • 4Poloni M, Facchetti D, Mai R, Micheli A, Agnoletti L, Francolini G, et al. Circulating levels of tumour necrosis factor-alpha and its soluble receptors are increased in the blood of patients with amyotrophic lateral sclerosis. Neurosci Lett 2000; 287: 211-4.
  • 5Troost D, Van den Oord J J, Vianney de Jong JM. Immunohistochemical characterization of the inflammatory infiltrate in amyotrophic lateral sclerosis. Neuropathol Appl Neurobiol 1990;16: 401-10.
  • 6Abe K, Abe Y, Saito H. Agmatine suppresses nitric oxide production in microglia. Brain Res 2000; 872: 141-8.
  • 7Piani D, Frei K, Do KQ, Cuenod M, Fontana A. Murine brain macrophages induce NMDA receptor mediated neurotoxicity in vitro by secreting glutamate. Neurosci Lett 1991; 133: 159-62.
  • 8Chao CC, Hu S, Peterson PK. Glia, cytokines, and neurotoxicity.Crit Rev Neurobiol 1995; 9: 189-205.
  • 9Levi G, Minghetti L, Aloisi F. Regulation of prostanoid synthesis in microglial cells and effects of prostacyclin E2 on microglial functions. Biochimie 1998; 80: 899-904.
  • 10Almer G, Guegan C, Teismann P, Naini A, Rosoklija G, Hays AEet al. Increased expression of the pro-inflammatory enzyme cyclooxygenase-2 in amyotrophic lateral sclerosis. Ann Neurol 2001: 49: 176-85.

同被引文献11

  • 1管小亭,王春雪,龙洁,资深.帕金森病患者外周血TNF-α浓度和IL-6质量浓度的检测及分析[J].首都医科大学学报,2004,25(2):233-235. 被引量:12
  • 2苏闻,陈海波,王新德.帕金森病治疗药物对患者外周血单核细胞分泌细胞因子的影响[J].中华老年医学杂志,2004,23(7):454-456. 被引量:4
  • 3张振馨.帕金森病的诊断[J].中华神经科杂志,2006,39(6):408-409. 被引量:616
  • 4Gayle DA, Ling Z, Tong C, et al. Lipopolysaccharide (LPS) induced dopamine cell loss in culture roles of tumor necrosis factor-alpha interleukin-1 beta,and nitric oxide. Brain Res Dev,2002,133:27-35.
  • 5Gadient RA, Otten UH. Interleukin-6 (IL-6): a moecule with both beneficial and destructive potentials. Prog Neurobiol,1997, 52:379-390.
  • 6Bessler H, Djaldetti R, Salman H, et al. IL-1 beta, IL-2, IL45 and TNF alpha production by peripheral blood mononuclear cell form patients with Parkinson' s diseas. Biomed Pharmacother, 1999, 53 : 141-145.
  • 7Bongioanni P, Castagna M, Maltinti S, et al. T lymphocyte tumor necrosis factor-alpha receptor binding in patients with Parkinson' s disease. J Neurol Sci, 1997, 149:41-45.
  • 8Hasegawa Y, Inagaki T, Sawada M, et al. Impaired cytokine production by peripheral blood mononuclear cells and monocytes macrophages in Parkinson' s disease. Acta Neurol Scand,2000,101 : 159-164.
  • 9Marttila RJ, Eskola J, Paivarinta M , et al. Immuonlogical status in Parkinson ' s disease. Adv Neurol, 1984,40:315.
  • 10Fisezer U,Piotrowska K, Korlak J, et al. The hnmuonlogical status in Parkinson' s disease. Med Labsci, 1991,48 : 196.

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部